APA
Colucci G., Labianca R., Di Costanzo F., Gebbia V., Cartenì G., Massidda B., Dapretto E., Manzione L., Piazza E., Sannicolò M., Ciaparrone M., Cavanna L., Giuliani F., Maiello E., Testa A., Pederzoli P., Falconi M., Gallo C., Di Maio M. & Perrone F. (20100409). Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Colucci Giuseppe, Labianca Roberto, Di Costanzo Francesco, Gebbia Vittorio, Cartenì Giacomo, Massidda Bruno, Dapretto Elisa, Manzione Luigi, Piazza Elena, Sannicolò Mirella, Ciaparrone Marco, Cavanna Luigi, Giuliani Francesco, Maiello Evaristo, Testa Antonio, Pederzoli Paolo, Falconi Massimo, Gallo Ciro, Di Maio Massimo and Perrone Francesco. 20100409. Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Colucci G., Labianca R., Di Costanzo F., Gebbia V., Cartenì G., Massidda B., Dapretto E., Manzione L., Piazza E., Sannicolò M., Ciaparrone M., Cavanna L., Giuliani F., Maiello E., Testa A., Pederzoli P., Falconi M., Gallo C., Di Maio M. and Perrone F. (20100409). Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Colucci Giuseppe, Labianca Roberto, Di Costanzo Francesco, Gebbia Vittorio, Cartenì Giacomo, Massidda Bruno, Dapretto Elisa, Manzione Luigi, Piazza Elena, Sannicolò Mirella, Ciaparrone Marco, Cavanna Luigi, Giuliani Francesco, Maiello Evaristo, Testa Antonio, Pederzoli Paolo, Falconi Massimo, Gallo Ciro, Di Maio Massimo and Perrone Francesco. Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20100409.